Invests in animal feed, sugar and oils, chemicals, energy, insurance, engineering and shipbuilding businesses

Janssen Pharmaceutica is a pharmaceutical company headquartered in Beerse, Belgium and owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen. In 1961, Janssen Pharmaceutica was purchased by New Jersey-based American corporation Johnson & Johnson, and became part of Johnson & Johnson Pharmaceutical Research and Development (J&J PRD), now renamed to Janssen Research and Development (JRD), which conducts research and development activities related to a wide range of human medical disorders, including mental illness, neurological disorders, anaesthesia and analgesia, gastrointestinal disorders, fungal infection, HIV/AIDS, allergies and cancer. Janssen and Ortho-McNeil Pharmaceutical have been placed in the Ortho-McNeil-Janssen group within Johnson & Johnson Company.

Dongguk University Industry-Academic Cooperation Foundation is for the promotion of tenants and entrepreneurship.

VALNEVA Austria GmbH, a subsidiary of Valneva SE, is a company headquartered in Vienna, Austria. The firm operates as a biotechnology company which develops and commercializes vaccines for infectious diseases. It was founded in 2013. Thomas Lingelbach, Fr��d��ric Jacotot and Franck Charles Marie Grimaud are the current co-CEOs of the firm.

Liuzhou Gengqing Technology Co., Ltd., established on 2014-11-27, The scope of business includes the research and experimental development of green seedlings and flowers,Cultivation and sales;Aquatic product sales;Gardening production and sales;Import and export trade of green seedlings and flowers;Forest tree seeds(urban green seedlings,flowers)Production and Wholesale(Limited to branch operations).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Onxeo is a biotechnology company that develops drugs for oncology. It offers Beleodaq, a histone deactylase inhibitor for the treatment of peripheral T-cell lymphoma; Livatag, a nanoparticle formulation of doxorubicin, which is in Phase III clinical trials for the treatment of primary liver cancer; Validive, a mucoadhesive buccal tablet that is in Phase II clinical trials for the prevention and the treatment of chemoradioation therapy-induced severe oral mucositis in patients with head and neck cancer; and Combo BelCHOP, which is Phase II clinical trials for the treatment of peripheral T-cell lymphoma. Onxeo is headquartered in Paris, France.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.

International food processor

Otsuka Pharmaceutical Factory, Inc. manufactures and distributes pharmaceutical and nutritional products. Its products include medical foods, hine E-gel, processlead, engelead, innerpower, oronine h ointment, urepearl plus lotion 10 and urepearl plus cream. The company was founded on September 1, 1921 and is headquartered in Naruto, Japan.

Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology called transcutaneous immunization (TCI). TCI taps into the unique benefits of a major group of antigen-presenting cells found in the outer layers of the skin to generate an enhanced immune response. Iomai is leveraging TCI to enhance the efficacy of existing vaccines, enable new vaccines that are viable only through transcutaneous administration and expand the global vaccine market. The company was incorporated in 1997 and is based in Gaithersburg, Maryland. Intercell USA, Inc. was formerly known as Iomai Corporation. As a result of the acquisition of Iomai Corporation by Intercell Ag, Iomai Corporation's name was changed. As of August 5, 2008, Intercell USA, Inc. operates as a subsidiary of Intercell Biomedical Research & Development AG.

Shandong Liuhe Group Co., Ltd. engages in the industries of animal feed manufacturing, meat processing and cooking, livestock and poultry breeding, importing and exporting trade, animal production and financial guarantee. The company was founded in 1995 and is headquartered in Qingdao, China.

Clinigen Group Plc engages in the provision of pharmaceutical products and services. It operates through the following segments: Commercial Medicines, Unlicensed Medicines, and Clinical Trial Services. The Commercial Medicines segment acquires rights to niche hospital-only and critical care products and also provides access to licensed and branded generic. The Unlicensed Medicines segment supplies unlicensed medicines to hospital pharmacists and physicians for patients with a high unmet medical need. The Clinical Trial Services offers comparator medicines and services to clinical trials and IITs. The company was founded by Andrew Leaver in June 2010 and is headquartered in Burton-on-Trent, the United Kingdom.

Zhenjiang Water Industry Co., Ltd., established on 1990-12-19, Business scope includes construction of water supply and drainage facilities,maintain,operate,manage;Urban organic matter co-processing engineering design,the construction,Operation and Recycling of Related Resources;Sponge city design,the construction,maintain,operate,manage.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Jiangsu Aosaikang Pharmaceutical Co. Ltd. develops and manufactures pharmaceutical chemicals and health-care products. It offers antibiotics and injections for the digestive, oncology, cardiovascular, and others. The company was founded on January 14, 2003 and is headquartered in Nanjing, China.